Literature DB >> 2270482

Linkage of early-onset familial breast cancer to chromosome 17q21.

J M Hall1, M K Lee, B Newman, J E Morrow, L A Anderson, B Huey, M C King.   

Abstract

Human breast cancer is usually caused by genetic alterations of somatic cells of the breast, but occasionally, susceptibility to the disease is inherited. Mapping the genes responsible for inherited breast cancer may also allow the identification of early lesions that are critical for the development of breast cancer in the general population. Chromosome 17q21 appears to be the locale of a gene for inherited susceptibility to breast cancer in families with early-onset disease. Genetic analysis yields a lod score (logarithm of the likelihood ratio for linkage) of 5.98 for linkage of breast cancer susceptibility to D17S74 in early-onset families and negative lod scores in families with late-onset disease. Likelihood ratios in favor of linkage heterogeneity among families ranged between 2000:1 and greater than 10(6):1 on the basis of multipoint analysis of four loci in the region.

Entities:  

Mesh:

Year:  1990        PMID: 2270482     DOI: 10.1126/science.2270482

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  596 in total

1.  The genetic epidemiology of early-onset epithelial ovarian cancer: a population-based study.

Authors:  J F Stratton; D Thompson; L Bobrow; N Dalal; M Gore; D T Bishop; I Scott; G Evans; P Daly; D F Easton; B A Ponder
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

2.  After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer.

Authors:  J Cui; A C Antoniou; G S Dite; M C Southey; D J Venter; D F Easton; G G Giles; M R McCredie; J L Hopper
Journal:  Am J Hum Genet       Date:  2000-12-27       Impact factor: 11.025

3.  Age and sex based genetic locus heterogeneity in type 1 diabetes.

Authors:  A D Paterson; A Petronis
Journal:  J Med Genet       Date:  2000-03       Impact factor: 6.318

4.  A model protocol evaluating the introduction of genetic assessment for women with a family history of breast cancer.

Authors:  J Gray; K Brain; P Norman; C Anglim; L France; G Barton; L Branston; E Parsons; A Clarke; J Sampson; E Roberts; R Newcombe; D Cohen; C Rogers; R Mansel; P Harper
Journal:  J Med Genet       Date:  2000-03       Impact factor: 6.318

5.  A genome screen of multiplex sibships with prostate cancer.

Authors:  B K Suarez; J Lin; J K Burmester; K W Broman; J L Weber; T K Banerjee; K A Goddard; J S Witte; R C Elston; W J Catalona
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

Review 6.  Functional domains of the BRCA1 and BRCA2 proteins.

Authors:  R Baer; W H Lee
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-10       Impact factor: 2.673

7.  Does risk factor epidemiology put epidemiology at risk? Peering into the future.

Authors:  M Susser
Journal:  J Epidemiol Community Health       Date:  1998-10       Impact factor: 3.710

Review 8.  Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility.

Authors:  M M de Jong; I M Nolte; G J te Meerman; W T A van der Graaf; J C Oosterwijk; J H Kleibeuker; M Schaapveld; E G E de Vries
Journal:  J Med Genet       Date:  2002-04       Impact factor: 6.318

9.  An additive genetic gamma frailty model for linkage analysis of diseases with variable age of onset using nuclear families.

Authors:  Hongzhe Li
Journal:  Lifetime Data Anal       Date:  2002-12       Impact factor: 1.588

10.  Finding genetic contributions to sporadic disease: a recessive locus at 12q24 commonly contributes to patent ductus arteriosus.

Authors:  Arya Mani; Seyed-Mahmoud Meraji; Roozbeh Houshyar; Jayaram Radhakrishnan; Alaleh Mani; Mehrabeh Ahangar; Tayebeh M Rezaie; Mohammad-Ali Taghavinejad; Behrooz Broumand; Hongyu Zhao; Carol Nelson-Williams; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.